Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

DEAR DR. ROACH: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn’t tell us how to ...

U.S. Rep. Kweisi Mfume (D-Md.-7) and Sen. Angela Alsobrooks (D-Md.) are teaming up on a new push to provide relief to those suffering from chronic lung conditions. Both members of Congress have put ...

Miles Lanham arrived at the University of Virginia eager to build something of his own. “I came into college knowing I wanted to start something,” said Lanham, now a third-year biomedical engineering ...

A new trial at Sheffield Children's Hospital will test whether a combined inhaler can better control asthma symptoms and attacks in youngsters. The study, which focuses on children aged six to 11, ...

ALBANY, N.Y. (NEWS10)—Making asthma inhalers more affordable— new legislation signed by Governor Hochul will eliminate out of pocket costs for the lifesaving medication. “It should not cost so much to ...

ALBANY — New Yorkers will soon be able to get an asthma inhaler for free. Gov. Kathy Hochul signed legislation Monday requiring insurance companies to cover the full cost of an asthma inhaler without ...

New Yorkers with asthma may soon be able to breathe a little easier. Gov. Kathy Hochul signed legislation Monday that will make inhalers free for many New Yorkers starting in 2027. Under the new law, ...

Researchers from UCLA and other health institutions found that some inhalers produce significant greenhouse gas emissions, highlighting the need for health care providers to consider their carbon ...

GameSpot may get a commission from retail offers. Are you scratching your head because you can't seem to unlock more weapon slots in The Outer Worlds 2? It's not just weapons, mind you. The types of ...

Oct 27 (Reuters) - Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR ...